These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37773301)

  • 1. Curcumin clarithromycin nano-form a promising agent to fight Helicobacter pylori infections.
    Mosallam FM; Bendary MM; Elshimy R; El-Batal AI
    World J Microbiol Biotechnol; 2023 Sep; 39(12):324. PubMed ID: 37773301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.
    Yonezawa H; Osaki T; Hanawa T; Kurata S; Ochiai K; Kamiya S
    PLoS One; 2013; 8(9):e73301. PubMed ID: 24039906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.
    Sakinc T; Baars B; Wüppenhorst N; Kist M; Huebner J; Opferkuch W
    BMC Res Notes; 2012 Oct; 5():603. PubMed ID: 23110798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
    Dang NQH; Ha TMT; Nguyen ST; Le NDK; Nguyen TMT; Nguyen TH; Pham TTH; Tran VH
    J Glob Antimicrob Resist; 2020 Sep; 22():620-624. PubMed ID: 32590188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene.
    Redondo JJ; Keller PM; Zbinden R; Wagner K
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):1-6. PubMed ID: 29111147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
    De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
    Makobongo MO; Einck L; Peek RM; Merrell DS
    PLoS One; 2013; 8(7):e68917. PubMed ID: 23935905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Encapsulated into Biocompatible Co-Polymer PLGA Nanoparticle Enhanced Anti-Gastric Cancer and Anti-Helicobacter Pylori Effect.
    Alam J; Dilnawaz F; Sahoo SK; Singh DV; Mukhopadhyay AK; Hussain T; Pati S
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):61-70. PubMed ID: 35092372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam.
    Tran VH; Ha TMT; Le PTQ; Phan TN; Tran TNH
    J Glob Antimicrob Resist; 2019 Mar; 16():87-91. PubMed ID: 30266639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting the Anti-Helicobacter Efficacy of Azithromycin through Natural Compounds: Insights From In Vitro, In Vivo, Histopathological, and Molecular Docking Investigations.
    Bendary MM; Elmanakhly AR; Mosallam FM; Alblwi NAN; Mosbah RA; Alshareef WA; Selim HMRM; Alhomrani M; Alamri AS; Safwat NA; Hamdan AME; Elshimy R
    Helicobacter; 2024; 29(4):e13110. PubMed ID: 39001634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
    Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
    J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin resistance in Helicobacter pylori and its molecular determinants in Northern Spain, 2013-2015.
    Tamayo E; Montes M; Fernández-Reyes M; Lizasoain J; Ibarra B; Mendarte U; Zapata E; Mendiola J; Pérez-Trallero E
    J Glob Antimicrob Resist; 2017 Jun; 9():43-46. PubMed ID: 28343971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
    Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
    J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
    Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
    J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-Time Polymerase Chain Reaction for the Detection of
    Noh JH; Ahn JY; Choi J; Park YS; Na HK; Lee JH; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JM
    Gut Liver; 2023 May; 17(3):375-381. PubMed ID: 35854654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
    Tongtawee T; Dechsukhum C; Matrakool L; Panpimanmas S; Loyd RA; Kaewpitoon SJ; Kaewpitoon N
    Asian Pac J Cancer Prev; 2015; 16(18):8281-5. PubMed ID: 26745073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
    Nobata K; Ina K; Ohta M; Kawamura-Sato K; Tsuzuki T; Ando T; Kusugami K
    Dig Liver Dis; 2002 Jul; 34(7):489-97. PubMed ID: 12236482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
    Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori.
    Hirata K; Suzuki H; Nishizawa T; Tsugawa H; Muraoka H; Saito Y; Matsuzaki J; Hibi T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S75-9. PubMed ID: 20586871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.